Stockreport

Rapport Therapeutics GAAP EPS of -$0.72 misses by $0.03 [Seeking Alpha]

Rapport Therapeutics, Inc.  (RAPP) 
PDF Ended the year with $490.5 million in cash, cash equivalents, and short-term investments, excluding restricted cash, which is expected to fund operations into the secon [Read more]